Kaboom Core Investors Club (fka )

[tryz]

SCRC...FOOD FOR THOUGHT INVESTORS & MASSIVE REVENUE POTENTIAL TO CHINA RAPIMEDS !!! > ... In its latest report, the IMS Institute highlights the following.....IMS Health Study Forecasts Global Spending on Medicines to Reach $1 Trillion Threshold in 2014, Driven by Greater Access
Growth Expected to Accelerate from Low Point in 2013 To 5-7 Percent in 2017;
Rising Number of Innovative New Drugs Expected to be Approved Over Next Five Years


Press Release: IMS Health – Tue, Nov 19, 2013 12:06 PM EST.. findings:

•Structural changes within healthcare systems globally are creating divergent trends. In the U.S., uncertainties with the implementation of the Affordable Care Act could result in a number of potential outcomes, ranging from: disparate enrollment levels of uninsured and under-insured populations; the extent to which there is a shift in focus on preventive medicines versus acute care; changes from fee-for-service to performance/outcomes-based payment models; and the degree of cost shifting to patients via higher deductibles and/or co-pays. With the aging population in Japan driving a rapid increase in demand for medicines, the government there has recently mandated that 60 percent of all prescribed off-patent drugs are to be dispensed as generics by 2018 – an action that would double current levels and is unprecedented in any country. In Europe, patients’ ability to utilize innovative medicines will be influenced by the impact of potential new austerity measures and the extent to which countries generate savings through greater use of generics. China, in the midst of a massive expansion of its healthcare system, will transform the medicines market with its goal of universal coverage by 2020; the country will represent 34 percent of total growth in global medicine spending over the next five years. .... http://finance.yahoo.com/news/ims-health-study-forecasts-global-170600581.html